NCT06677918View on ClinicalTrials.gov

Clinical Trial Investigating the Effects of EP395 Following an Inhaled Endotoxin Challenge in Healthy Adults

PHASE1RecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Healthy Volunteer
Interventions
DRUG

EP395

Capsule for oral use

DRUG

Placebo

Capsule for oral use

Trial Locations (1)

30625

RECRUITING

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Division of Clinical Airway Research, Hanover

Sponsors
All Listed Sponsors
collaborator

FGK Clinical Research GmbH

INDUSTRY

lead

EpiEndo Pharmaceuticals

INDUSTRY